HIKMA PHARMACEUTICALS USA INC. — TTAB Proceedings

HIKMA PHARMACEUTICALS USA INC. is a party to 2 TTAB proceedings.

Proceedings

Proceeding 98180038 — Extensions of Time to Oppose, Terminated (filed 2024-05-29) against Boehringer Ingelheim International GmbH as defendant
Proceeding 92083399 — Cancellations, Terminated (filed 2023-10-04) against Bluebird Bio, Inc. as plaintiff

2024-05-29: 98180038 — EXTENSION OF TIME GRANTED involving Boehringer Ingelheim International GmbH
2024-05-29: 98180038 — FIRST 90-DAY REQUEST TO EXT TIME TO OPPOSE involving Boehringer Ingelheim International GmbH
2024-03-07: 92083399 — COMMR ORDER CANCELLING REG involving Bluebird Bio, Inc.
2024-03-07: 92083399 — COMMR ORDER CANCELLING REG involving Bluebird Bio, Inc.
2024-03-07: 92083399 — TERMINATED involving Bluebird Bio, Inc.
2024-03-07: 92083399 — COMMR ORDER CANCELLING REG involving Bluebird Bio, Inc.
2024-03-06: 92083399 — REFUND ISSUED - TRADEMARK RULE 2.114(A)(2) involving Bluebird Bio, Inc.
2024-03-06: 92083399 — REFUND IN PROCESS - TRADEMARK RULE 2.114(A)(2) involving Bluebird Bio, Inc.
2024-01-13: 92083399 — BOARD'S DECISION: GRANTED involving Bluebird Bio, Inc.
2023-11-30: 92083399 — NOTICE OF DEFAULT involving Bluebird Bio, Inc.
2023-10-11: 92083399 — PENDING, INSTITUTED involving Bluebird Bio, Inc.
2023-10-11: 92083399 — NOTICE AND TRIAL DATES SENT; ANSWER DUE: involving Bluebird Bio, Inc.
2023-10-04: 92083399 — FILED AND FEE involving Bluebird Bio, Inc.